HIV medications are prescription medicines used as part of antiretroviral therapy (ART) to control HIV and reduce the amount of virus in the body. This guide explains common HIV medication names, major drug classes, combination treatments, and factors that can influence how a treatment regimen is selected.
HIV medications are medicines used to prevent HIV from multiplying in the body. Treatment is called antiretroviral therapy, or ART, and usually involves a combination of medicines that work at different stages of the HIV life cycle.
ART is recommended for people with HIV, and treatment is generally started as soon as possible after diagnosis. The goal is to reduce the viral load, protect the immune system, and help prevent HIV from progressing.
There are many FDA-approved HIV medicines in the United States. They are organized into different drug classes based on how they interfere with HIV replication. A person's treatment regimen is selected based on factors such as previous treatment, other health conditions, potential drug interactions, side effects, convenience, and cost.
People searching for an HIV medications names list may encounter both generic drug names and brand names. The same medicine may also be available as part of a combination product containing two or more active ingredients.
Some commonly recognized HIV medicines include:
These medicines belong to different classes and are not interchangeable. The FDA-approved list also includes combination medicines that place multiple active ingredients into one tablet or treatment regimen.
Because HIV treatment changes over time, a current medication list is more useful than relying on older lists that may include discontinued products or medicines that are no longer commonly used.
The term antiretroviral medications covers several different classes of HIV medicines. Each class interferes with HIV in a different way.
NRTIs interfere with reverse transcriptase, an enzyme HIV needs to make copies of itself.
Examples include emtricitabine, lamivudine, abacavir, tenofovir alafenamide, tenofovir disoproxil fumarate, and zidovudine. These medicines are frequently used as components of combination treatment.
NNRTIs also target reverse transcriptase but work through a different mechanism.
Examples include doravirine, rilpivirine, and etravirine. Some older medicines in this class have been discontinued, which is another reason current treatment information matters when comparing HIV medication options.
Integrase inhibitors, often called INSTIs, interfere with integrase, an HIV enzyme needed for viral replication.
Examples include dolutegravir, bictegravir, raltegravir, and cabotegravir. INSTIs are an important part of many modern HIV treatment approaches.
Protease inhibitors interfere with another enzyme HIV uses to produce mature viral particles.
Examples include darunavir, atazanavir, ritonavir, and tipranavir. Ritonavir can also be used as a pharmacokinetic enhancer to increase the effectiveness of another medicine in a regimen.
Other classes include fusion inhibitors, CCR5 antagonists, attachment inhibitors, post-attachment inhibitors, and capsid inhibitors.
These medicines work at different stages of the HIV life cycle. They may be particularly relevant in specific treatment situations, including cases involving previous treatment or resistance.
Most people do not simply choose one HIV medication from a list. Instead, healthcare professionals select a complete HIV treatment regimen.
A regimen may contain two or more medicines from different drug classes. Some combinations are packaged together as a single tablet, while others involve multiple pills or injectable medicines.
Single-tablet regimens can combine several active ingredients into one pill. For people who have difficulty taking multiple medicines, the convenience of a simpler regimen may be an important consideration.
Examples of combination HIV medicines approved in the United States include Biktarvy, Dovato, Triumeq, Juluca, Odefsey, Symtuza, and Cabenuva. The appropriate option depends on the individual's medical situation rather than simply choosing the most familiar brand.
There is no single HIV medication that is appropriate for everyone.
When selecting HIV prescription medications, healthcare professionals may consider:
These factors can make two otherwise similar-looking treatment options very different for an individual patient.
Another important distinction is between oral HIV medications and long-acting injectable treatments. Some injectable medicines are administered less frequently than daily pills, but they are not appropriate for everyone and require administration according to a healthcare provider's schedule.
One of the major goals of HIV treatment is to reduce the amount of HIV in the blood, known as the viral load.
When treatment works effectively and is taken as prescribed, viral load can become very low or undetectable. Regular monitoring helps healthcare professionals determine how well treatment is working and whether changes may be needed.
Medication adherence is an important part of HIV treatment. Missing doses or stopping treatment without medical guidance can interfere with treatment effectiveness and may increase the risk of drug resistance.
For this reason, treatment decisions should be based on an ongoing discussion with a qualified healthcare professional rather than on a medication name alone.
The price of HIV medications can vary substantially depending on the specific medicine, formulation, insurance coverage, pharmacy, and assistance options available.
Brand-name and generic availability can affect the overall cost. Combination products may also have different pricing and coverage rules from individual medicines.
Insurance plans can have their own formularies, deductibles, copayments, and prior authorization requirements. Some people may also qualify for medication assistance or other healthcare support programs.
When comparing HIV medication costs, it is useful to look beyond the advertised price and consider the total cost of the treatment regimen, including medical appointments, laboratory monitoring, insurance requirements, and administration costs for injectable medicines.
A medication name alone does not tell you whether it is the right option.
For people researching HIV treatment options, useful comparison points include:
Medication class: Different classes work at different stages of the HIV life cycle.
Dosing schedule: Some treatments involve daily oral medication, while certain injectable options are administered less frequently.
Combination ingredients: A single tablet may contain multiple HIV medicines, potentially simplifying the treatment schedule.
Drug interactions: Other prescription medicines, over-the-counter products, and supplements can affect treatment choices.
Side effects: Different medicines can have different potential adverse effects, so these should be discussed with a healthcare professional.
Cost and coverage: Insurance formularies, copayments, assistance programs, and generic availability can influence affordability.
Treatment history: Previous medicines and resistance patterns can affect which options remain appropriate.
This is why comparing HIV medications is more complicated than creating a simple list from cheapest to most expensive or newest to oldest.
People researching HIV prescription medications may want to ask their healthcare provider:
Having these questions answered can make it easier to understand the differences between available treatment approaches.
HIV medications are commonly called antiretroviral medicines or antiretrovirals. The overall treatment approach is called antiretroviral therapy, or ART.
The United States has approved more than 50 HIV medicines for treatment, including individual medicines and combination products. The available list can change as new medicines are approved and older products are discontinued.
Yes. HIV treatment medicines are prescription medications and should be used according to a healthcare professional's treatment plan.
Many HIV treatments involve daily oral medication. Some treatments are available as long-acting injections that are administered less frequently, but injectable options are not appropriate for everyone.
Yes. Some HIV treatment regimens combine multiple active medicines into a single tablet or capsule. Combination treatment can simplify dosing for some people.
The choice depends on individual factors such as previous treatment, other health conditions, potential interactions, side effects, resistance, convenience, and cost. A healthcare professional can evaluate these factors when selecting a treatment regimen.